Search Results - "Musina, Z. N."

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system by Teptsova, T. S., Musina, N. Z., Omelyanovsky, V. V.

“…Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold, incremental cost-effectiveness ratio) is used as one of the…”
Get full text

Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program by Bessonova, T. O., Mukhortova, P. A., Teryan, R. A., Bagdasarov, A. D., Musina, N. Z.

“…Objective: to evaluate the clinical and economic feasibility of expanding the preferential drug provision (PDP) program for adult patients at very high…”
Get full text

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making by Lemeshko, V. A., Musina, N. Z., Omelyanovskiy, V. V.

“…Aim. Development of a tool for the evaluation of the therapeutic value of anticancer drugs based on multi-criteria analysis of decision making. Materials and…”
Get full text

Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies by Perova, K. A., Shchurov, D. G., Blinov, D. V., Bashmakova, N. V., Musina, N. Z.

“…Objective : to evaluate clinical-economic feasibility and impact of follitropin alfa on the state healthcare budget of the Russian Federation in the population…”
Get full text

Evolution of healthcare provider payment mechanisms by Omelyanovskiy, V. V., Sisigina, N. N., Fedyaeva, V. K., Musina, N. Z.

“…Methods of payment to care providers constitute an essential part of the healthcare financing system; these mechanisms determine the motivation of service…”
Get full text

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia by Omelyanovsky, V. V., Fedyaeva, V. K., Musina, N. Z.

“…In the article, we analyze the current version of Government Regulation No. 871 where the principles of health technologies assessment (HTA) and the…”
Get full text

Affordability of in vivo gene therapy. Problems and potential solutions by Omelyanovskiy, V. V., Musina, N. Z., Lemeshko, V. A., Antonov, A. A., Gorkavenko, F. V.

“…Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs.Materials and Methods. The first stage of the review included…”
Get full text

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES by Musina, N. Z., Fedyaeva, V. K.

“…This report addresses the ways of calculating QALY (Quality-adjusted life-year). OutsideRussia, a standardized methodology to calculate QALY is in use; such an…”
Get full text

IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET by Lemeshko, V. A., Musina, N. Z., Fedyaeva, V. K.

“…The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug…”
Get full text

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions by Hachatryan, G. R., Teptsova, T. S., Lemeshko, V. A., Musina, N. Z.

“…The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017. Materials and…”
Get full text

Concept of value-based healthcare by Musina, N. Z., Omelyanovskiy, V. V., Gostischev, R. V., Sukhorukikh, O. A., Fedyaeva, V. K., Sisigina, N. N., Shchurov, D. G.

“…This article contains the aims and main principles of the concept of value-based healthcare (VBHC). The relevance of the implementation of this approach into…”
Get full text

Introduction of medical products into healthcare practice and costs reimbursement: European experience by Omelyanovsky, V. V., Otstavnov, S. S., Musina, N. Z., Dombrovskii, V. S.

“…in the present article, we review the ways of introducing medical products into healthcare practice in countries of the european Union and compare them with…”
Get full text

PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS by Musina, N. Z., Tarasov, V. V.

“…The article describes a new approach to the use of economic evaluation at the stage of planning and organization of clinical trials and considers the examples…”
Get full text

International experience in determining the cost-effectiveness thresholds by Bezdenezhnykh, T. P., Musina, N. Z., Fedyaeva, V. K., Tepcova, T. S., Lemeshko, V. A., Omelyanovsky, V. V.

“…The article reviews international methodological guidelines, regulatory documents and existing approaches to the determination of the costeffectiveness…”
Get full text

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies by Teptsova, T. S., Bezdenezhnyh, T. P., Fedyaeva, V. K., Musina, N. Z, Hachatryan, G. R., Tarasov, V. V.

“…The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system…”
Get full text

EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS by Musina, N. Z., Omelyanovskiy, V. V., Krasheninnikova, A. V.

“…Early health technologies assessment (HTA) is a form of HTA, which takes place at early stages of the life cycle of medical technology. This method allows us…”
Get full text

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS by Fedyaeva, V. K., Omelyanovskiy, V. V., Musina, N. Z., Khachatryan, G. R., Ivakhnenko, O. I.

“…Among the most important aspects of the health policy are the methods for pricing of medicines, especially of innovative medicines. In many countries, the…”
Get full text

Review of the current approaches to the assessment of the drug innovative potential worldwide by Musina, N. Z., Fedyaeva, V. K., Omel’yanovskii, V. V., Khachatryan, G. R., Gerasimova, K. V., Lemeshko, V. A., Konchits, K. P.

“…A set of criteria for assessing the innovative potential of drugs (therapeutic value) have been developed and are widely used elsewhere. These approaches allow…”
Get full text

Prospects of Using Brain-Derived Neurotrophic Factor for the Treatment of Optic-Nerve Neuropathy (A Review) by Khalin, I. V., Musina, N. Z., Alyautdin, R. N., Romanov, B. K., Bunatyan, N. D.

“…The literature on the use of brain-derived neurotrophic factor (BDNF) as a promising agent capable of preventing the loss of retinal ganglion cells was…”
Get full text

Degradation of poly(terphenylenephthalide) at high temperatures by Kraikin, V. A., Musina, Z. N., Galkin, E. G., Kuznetsov, S. I., Egorov, A. E., Salazkin, S. N.

Get full text